POST-TRANSPLANT OUTCOMES OF PATIENTS WITH MDS AND AML AFTER RECEIVING HYPOMETHYLATING AGENT THERAPY COMBINED WITH THE TIM-3 INHIBITOR, MBG453

EHA Library, Andrew Brunner, 294745

MUTATIONS IN RAS PATHWAY GENES CORRELATE WITH TYPE OF FAILURE TO AZACITIDINE: GENOMIC ANALYSIS AT RANDOMIZATION ONTO THE INSPIRE TRIAL

EHA Library, Koichi Takahashi, 294746

CIRCULATING CONCENTRATIONS OF HMGB1 IN PATIENTS WITH MYELODYSPLASTIC SYNDROME: EXPLORATORY STUDY

EHA Library, Elia Apodaca, 294747

MDS IRON ROAD: AN INTERNET-BASED ALGORITHM FOR THE DIAGNOSIS, WORKUP AND MANAGEMENT OF IRON OVERLOAD (IOL) IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) FROM THE CANADIAN CONSORTIUM ON MDS (CCMDS)

EHA Library, Heather Leitch, 294748

ESTIMATED GLOMERULAR FILTRATION RATE INDEPENDENTLY PREDICTS OUTCOME OF AZACYTIDINE THERAPY IN MDS. RESULTS FROM THE HELLENIC NATIONAL REGISTRY OF MYELODYSPLASTIC AND HYPOPLASTIC SYNDROMES.

EHA Library, Ioannis Kotsianidis, 294749

A THREE-PARAMETER SCORE BASED ON BONE MARROW IMMUNOPHENOTYPING IS COMPLEMENTARY TO IPSS-R FOR PROGNOSIS OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES.

EHA Library, Irene Lorand-Metze, 294750

TRANSFORMATION FROM MYELODYSPLASTIC SYNDROME AND RESEMBLES, IDIOPATHIC CYTOPENIA AND CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE, TO ACUTE MYELOID LEUKEMIA.

EHA Library, Volkan Bas, 294751

A RANDOMIZED, CROSSOVER STUDY TO EVALUATE THE EFFECTS OF PEVONEDISTAT ON THE QTC INTERVAL IN PATIENTS WITH ADVANCED MALIGNANCIES

EHA Library, Xiaofei Zhou, 294752

INTERIM RESULTS FROM AN ONGOING PHASE 1/2 CLINICAL TRIAL OF TAGRAXOFUSP (SL-401), A CD123-DIRECTED THERAPY, IN PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)

EHA Library, Mrinal M. Patnaik, 294753

DIACYLGLYCEROL KINASE Z DEFICIENCY TRIGGERS EARLY SIGNS OF APLASTIC ANEMIA IN MICE

EHA Library, Miguel Martin Salgado, 294754

UM171 STIMUALTES THE HEMATOPOIETIC DIFFERENTIATION OF HUMAN INDUCED PLURIPOTENT STEM CELLS OF PATIENTS WITH APLASTIC ANEMIA

EHA Library, Maria Florencia Tellechea, 294755

STUDY OF MOLECULAR, FLOW-CYTOMETRIC CHARACTERISTICS AND LONG-TERM OUTCOME OF PATIENTS WITH IDIOPATHIC CYTOPENIA OF UNDETERMINED SIGNIFICANCE AND ISOLATED NEUTROPENIA (ICUS-N)

EHA Library, Stavros Papadakis, 294756

THE ROLE OF DECREASED TIM3 EXPRESSION OF NK CELLS IN THE IMMUNE PATHOGENESIS OF SEVERE APLASTIC ANEMIA

EHA Library, Chunyan Liu, 294757

A ZEBRAFISH MODEL FOR SEVERE CONGENITAL NEUTROPENIA WITH HAX1 DEFICIENCY

EHA Library, Narges Aghaallaei, 294758

LONG NON-CODING RNA FAM157C CONTRIBUTED TO THE PROLIFERATION OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA CLONES

EHA Library, Rong Fu, 294759

PHENOTYPIC CHANGES CAUSED BY NOVEL SNV OF RPS7 GENE

EHA Library, AGATA KUBICKOVA, 294760

CELLULAR AND MOLECULAR MECHANISMS UNDERLYING THE ALTERED IN VITRO CAPILLARY-LIKE CAPABILITY OF SHWACHMAN-DIAMOND SYNDROME MESENCHYMAL STROMAL CELLS

EHA Library, Gloria Bedini, 294761

DEVELOPMENT OF A COMPOSITE ENDPOINT TO EVALUATE TREATMENT BENEFIT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Austin Kulasekararaj, 294762

WHOLE GENOME SEQUENCING REVEALS BROAD DIAGNOSTIC HETEROGENEITY IN PATIENTS WITH FEATURES RESEMBLING DIAMOND-BLACKFAN ANAEMIA

EHA Library, Josu de la Fuente, 294763

LANDSCAPE OF GENETIC VARIATIONS IN A COHORT OF CHILDREN WITH BONE MARROW FAILURE (BMF) USING A TARGETED NEXT GENERATION SEQUENCING (NGS) APPROACH

EHA Library, Prashant Chhabra, 294764

STROMAL PRECURSORS IN THE BONE MARROW OF UNTREATED APLASTIC ANEMIA PATIENTS

EHA Library, Alena Dorofeeva, 294765

THE ROLE OF LNCRNA-AF117829.1 IN THE IMMUNOPATHOGENESIS OF CD8+ T CELLS IN PATIENTS WITH SEVERE APLASTIC ANEMIA

EHA Library, Rong Fu, 294767

OUTCOMES OF PATIENTS WITH MONOSOMY 7 EVOLVED FROM SEVERE APLASTIC ANEMIA: TRANSPLANT VERSUS CHEMOTHERAPY AND SUPPORTIVE CARE

EHA Library, Emma Groarke, 294768

ORAL CXCR4 ANTAGONIST MAVORIXAFOR TREATMENT IN PATIENTS WITH WHIM SYNDROME: RESULTS OF AN OPEN LABEL PHASE 2 STUDY WITH LONG-TERM EXTENSION.

EHA Library, Sarah Cohen, 294769

EFFECTIVENESS OF ECULIZUMAB TREATMENT IN PATIENTS AGED ≥ 65 YEARS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH): RESULTS FROM THE INTERNATIONAL PNH REGISTRY

EHA Library, Jong Wook Lee, 294770

EFFECTS OF AN L-LEUCINE ADMINISTRATION IN DIAMOND-BLACKFAN ANEMIA PATIENTS

EHA Library, Dagmar Pospisilova, 294771

EFFECTS OF ORAL, FACTOR D INHIBITOR DANICOPAN ON TRANSFUSION RATES IN TRANSFUSION DEPENDENT PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) PATIENTS WITH A SUB-OPTIMAL RESPONSE TO ECULIZUMAB: PHASE 2 STUDY

EHA Library, Austin Kulasekararaj, 294772

HIGH-DOSE ROMIPLOSTIM ACCELERATES HEMATOLOGIC RECOVERY IN PATIENTS WITH APLASTIC ANEMIA REFRACTORY TO ELTROMBOPAG

EHA Library, Kohei Hosokawa, 294774

FLUDARABINE ALLOWS REDUCTION IN CONDITIONING INTENSITY TO ABROGATE THE INCREASED RISK OF GUT AND LUNG TOXICITY IN TRANSPLANTATION FOR DIAMOND BLACKFAN ANAEMIA WITHOUT IMPACT IN CHIMERISM STATUS

EHA Library, Josu de la Fuente, 294775

NEXT-GENERATION SEQUENCING GENE-PANELS FOR THE DETECTION OF TRANSFORMATION TO MDS/AML IN CHILDREN AND YOUNG ADULTS WITH ACQUIRED OR INHERITED CYTOPENIAS

EHA Library, Orna Steinberg Shemer, 294776

POZELIMAB INHIBITS HEMOLYSIS IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)

EHA Library, Jun-Ho Jang, 294777

INFECTIONS DURING ECULIZUMAB THERAPY IN A DUTCH POPULATION OF PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Charlotte Schaap, 294778

AN INTERIM ANALYSIS OF A PHASE 2 STUDY EVALUATING THE EFFICACY, SAFETY AND PHARMACOKINETICS OF INTRAVENOUS RAVULIZUMAB 100 MG/ML FORMULATION IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Alexander Röth, 294779

AN OPTIMIZED DOSING STRATEGY FOR CROVALIMAB IN TREATMENT OF COMPLEMENT-INHIBITOR-NAIVE OR -EXPERIENCED PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)

EHA Library, Julia Ramos, 294780

CYTOKINE PROFILE IN NEWLY DIAGNOSED CASES OF APLASTIC ANEMIA AND ITS CORRELATION WITH THE SEVERITY AND TREATMENT OUTCOMES IN APLASTIC ANEMIA

EHA Library, Rahul Vatsayan, 294781

CLINICAL AND MOLECULAR CHARACTERISTICS OF CHILDREN WITH SEVERE CHRONIC NEUTROPENIA: A SINGLE CENTER EXPERIENCE IN ARGENTINA

EHA Library, Maria Florencia Mininni, 294782

USE OF PROPHYLACTIC ANTIBIOTICS IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATED WITH ECULIZUMAB

EHA Library, Christopher J. Patriquin, 294783

LOW PLASMA HAPTOGLOBIN AND ENDOTHELIAL INJURY IN HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

EHA Library, Jon Badiola, 294784

SEX HORMONE LEVELS, TELOMERE LENGTH, AND EXPRESSION OF POTENTIAL REGULATORY SITES OF SEX HORMONE-TELOMERE IN PATIENTS WITH CHRONIC ACQUIRED APLASTIC ANEMIA

EHA Library, Ruirong Xu, 294785

REVEALING TRANSCRIPTOME DEREGULATION UPON GENOMIC COMPLEXITY IN MULTIPLE MYELOMA.

EHA Library, Bachisio Ziccheddu, 294786

RESPONSE TO BLOCKADE OF THE INHIBITORY IMMUNE CHECKPOINT TIGIT PROMOTES ANTI-TUMOR IMMUNITY IN MULTIPLE MYELOMA

EHA Library, Carlos Fernández de Larrea, 294787

EXOME SEQUENCING OF MULTIPLE MYELOMA RESIDUAL CELLS: TOWARDS IDENTIFICATION OF DRUGGABLE TARGETS FOR PERSONALIZED TREATMENT

EHA Library, Martina Zátopková, 294788

BLOCKING OF TRANSIENT RECEPTOR POTENTIAL VANILLOID1 (TRPV1) PROMOTES TERMINAL MITOPHAGY IN MULTIPLE MYELOMA, DISTURBING CALCIUM HOMEOSTASIS AND TARGETING UBIQUITIN PATHWAY AND BORTEZOMIB-INDUCED UPR

EHA Library, Katia Beider, 294789

EXPRESSION LEVELS OF P53 MRNA ISOFORMS REFINE PROGNOSIS IN MULTIPLE MYELOMA

EHA Library, Elizabeta A. Rojas, 294791

CELL-FREE DNA ANALYSIS FOR THE DETECTION OF MYD88 AND CXCR4 MUTATIONS IN IGM MONOCLONAL GAMMOPATHIES; AN UPDATE WITH CLINICOPATHOLOGICAL CORRELATIONS

EHA Library, Ioannis Ntanasis-Stathopoulos, 294793

THE ROLE OF VASCULAR PHENOTYPE IN THE DEVELOPMENT OF CARFILZOMIB-INDUCED HYPERTENSION

EHA Library, Panagiotis Efentakis, 294795

USEFULNESS OF CIRCULATING CELL-FREE DNA TO DEFINE HOW MULTIPLE MYELOMA SPREAD AND DISSEMINATE THROUGHOUT THE BONE MARROW IN NEWLY DIAGNOSED PATIENTS

EHA Library, Marina Martello, 294796

SINGLE PLASMA CELL TRANSCRIPTOME ANALYSIS IN POEMS SYNDROME

EHA Library, Yusuke Isshiki, 294797

IRON TRAFFICKING PROMOTES BORTEZOMIB RESISTANCE IN MULTIPLE MYELOMA

EHA Library, Alessandro Barbato, 294799

BIALLELIC DELETION OF CHROMOSOME 16P ENCOMPASSING THE BCMA LOCUS AS A TUMOR-INTRINSIC RESISTANCE MECHANISM TO BCMA-DIRECTED CAR T IN MULTIPLE MYELOMA

EHA Library, Leo Rasche, 294800

SUPERIOR ANTI-TUMOR ACTIVITY OF HEXABODY®-CD38 IN PRECLINICAL MODELS OF MULTIPLE MYELOMA, B CELL LYMPHOMA AND ACUTE MYELOID LEUKEMIA

EHA Library, Ida H. Hiemstra, 294801

LNCRNAS AS NOVEL PARTNERS OF FUSION TRANSCRIPTS IN MULTIPLE MYELOMA

EHA Library, Ane Amundarain, 294802

GERMLINE PREDICTORS OF IMMUNE DYSREGULATION IN MULTIPLE MYELOMA

EHA Library, Moritz Binder, 294803

CHARACTERIZATION OF GSK2606414, A SELECTIVE AND POTENT PERK INHIBITOR WITH EFFICACY IN MULTIPLE MYELOMA

EHA Library, Tina Bagratuni, 294804

NKTR-255 AS A NOVEL IMMUNOTHERAPEUTIC APPROACH TO RESTORE INNATE AND ADAPTIVE IMMUNE REPERTOIRE IN MULTIPLE MYELOMA

EHA Library, Rafael Alonso Fernández, 294805

NELFINAVIR INHIBITS PROTEASOME RE-SYNTHESIS IN MULTIPLE MYELOMA: THE TCF11/NRF1 PATHWAY AS A THERAPEUTIC TARGET

EHA Library, František Sedlák, 294806

RNA AND DNA SEQUENCING REVEAL MARKERS OF RESPONSE TO THE XPO1 INHIBITOR ELTANEXOR IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM)

EHA Library, Christopher Walker, 294807

MULTIPLE MYELOMA PATIENTS CARRY A SUBSTANTIAL NUMBER OF POTENTIALLY HARMFUL GERMLINE VARIANTS

EHA Library, Marja Hakkarainen, 294808

NR2F1 GENE REGULATES MACROPHAGE POLARIZATION IN MULTIPLE MYELOMA DRUG RESISTANCE

EHA Library, Danfeng Zhang, 294809

PERIPHERAL BLOOD IMMUNE PROFILING OF MULTIPLE MYELOMA PATIENTS AT DIAGNOSIS; CORRELATIONS WITH CIRCULATING PLASMA CELLS

EHA Library, Evangelos Terpos, 294810

PHARMACODYNAMIC RESPONSES DRIVE DOSE/SCHEDULE SELECTION OF CC-92480, A NOVEL CELMOD AGENT, IN A PHASE 1 DOSE-ESCALATION STUDY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Lilly Wong, 294811

THE NOVEL CELMOD AGENT CC-92480: TRANSLATION OF PRECLINICAL DATA TO A PHASE 1 CLINICAL TRIAL DESIGN

EHA Library, Lilly Wong, 294812

INHIBITION OF S100A9 WITH TASQUINIMOD DEMONSTRATES POTENT ANTI-TUMOR ACTIVITY IN PRE-CLINICAL MODELS OF MULTIPLE MYELOMA

EHA Library, Cindy Lin, 294813

AMINOPEPTIDASE EXPRESSION IN MULTIPLE MYELOMA ASSOCIATES WITH DISEASE PROGRESSION AND SENSITIVITY TO MELFLUFEN

EHA Library, Juho Miettinen, 294814

IMPACT OF AGING AND HYPERLIPIDAEMIA ON METFORMIN CARDIOPROTECTION AGAINST CARFILZOMIB-INDUCED CARDIOTOXICITY IN VIVO

EHA Library, Panagiotis Efentakis, 294815

COMPLEMENT C3A ACTIVATES OSTEOCLASTS BY REGULATING THE PI3K/PDK1/SGK3 PATHWAY IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Rong Fu, 294816

RNA DEMETHYLASE ALKBH5 PROMOTED TUMORIGENESIS VIA REGULATING HIPPO SIGNAL PATHWAY AND MYELOMA STEM CELL IN MULTIPLE MYELOMA

EHA Library, Yu Tingting, 294817

STUDY ON METHYLATION OF RAS ASSOCIATION DOMAIN FAMILY 10 GENE PROMOTER IN MULTIPLE MYELOMA

EHA Library, Rong Fu, 294818

THE ASSOCIATION OF CALCIUM BINDING PROTEINS S100A8 AND S100A9 WITH DRUG RESPONSE IN MULTIPLE MYELOMA

EHA Library, Minxia Liu, 294819

MELFLUFEN EFFICACY IN MULTIPLE MYELOMA WITH TP53 ABERRATIONS

EHA Library, Ana Slipicevic, 294820

INNATE CD8 T-CELLS AND INKT LYMPHOCYTES IN MONOCLONAL GAMMOPATHY

EHA Library, Cécile Gruchet, 294821

THE ADAPTIVE RESPONSE TO TRYPTOPHAN DEPRIVATION PERTURBS CD38 EXPRESSION AND MITOCHONDRIAL NETWORK TO PRESERVE AVAILABILITY OF INTRACELLULAR NAD+

EHA Library, ALESSANDRA ROMANO, 294822

SELECTIVE KILLING MULTIPLE MYELOMA CELLS BY TARGETING FREE LIGHT CHAIN SECRETION, ENDOPLASMIC RETICULUM STRESS AND UNFOLDED PROTEIN RESPONSE USING THE COMBINATION OF VALPROATE AND NICLOSAMIDE (VAN)

EHA Library, Yao Jiang, 294823

MALDI-TOF MASS SPECTROMETRY IN SERUM FOR THE FOLLOW-UP OF NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH DARATUMUMAB-BASED COMBINATION THERAPY

EHA Library, Marion Eveillard, 294824

THE ROLE OF MICRORNAS IN THE PATHOGENESIS OF AL AMYLOIDOSIS

EHA Library, Hila Fishov, 294825

ANALYSIS OF SERUM CELL-FREE DNA IN MULTIPLE MYELOMA WITH OVEREXPRESSION OF MAF FAMILY GENES

EHA Library, Takuto Tachita, 294826

COMBINED INHIBITION OF XPO1 AND EIF4E PREVENTS PROTEIN TRANSLATION AND HAS SYNERGISTIC ANTI-MYELOMA EFFECTS

EHA Library, Shirong Li, 294827

PD-1- AND TIM-3-EXPRESSING T CELLS INCREASE PROLIFERATIVE ABILITY AND PARTIALLY RETAIN FUNCTIONAL PROPERTIES AT EARLY POST-TRANSPLANT PERIOD IN MULTIPLE MYELOMA PATIENTS

EHA Library, Egor Batorov, 294828

DETECTION OF PHENOTYPICAL CLONAL EVOLUTION BY MULTI-DIMENSIONAL FLOW CYTOMETRY AFTER THE FIRST LINE TREATMENT IN PATIENTS DIAGNOSED WITH MULTIPLE MYELOMA

EHA Library, Elena Paumard Rodríguez, 294829

PROTEIN KINASE CK1ALPHA CONTROLS PLASMA CELLS AND STROMAL CELLS RUNX2 EXPRESSION POTENTIALLY AFFECTING THE MULTIPLE MYELOMA-ASSOCIATED BONE DISEASE

EHA Library, Anna Fregnani, 294830

AUTOLOGOUS NK CELL-BASED IMMUNOTHERAPY FOR MAINTENANCE TREATMENT OF MULTIPLE MYELOMA

EHA Library, Hareth Nahi, 294831

MELFLUFEN IS A HIGHLY EFFECTIVE ANTI-NEOPLASTIC AGENT IN BORTEZOMIB-RESISTANT MULTIPLE MYELOMA MODELS

EHA Library, Konstantin Byrgazov, 294832

FLOWCT: A SEMI-AUTOMATED WORKFLOW FOR DECONVOLUTION OF IMMUNOPHENOTYPIC DATA AND OBJECTIVE REPORTING ON LARGE DATASETS

EHA Library, Catarina Maia, 294833

EXPRESSION SIGNIFICANCE OF CRL4-CRBN PROTEINS COMPLEX IN MULTIPLE MYELOMA PATIENTS TREATED WITH IMMUNOMODULATORY DRUGS.

EHA Library, Joanna Barankiewicz, 294834

SOLITARY PLASMOCYTOMA CAN BE STRATIFIED BY NEXT GENERATION SEQUENCING

EHA Library, Marguerite Vignon, 294835

A SAME DAY CYTOCHROME C RELEASE ASSAY PREDICTS APOPTOTIC RESPONSE TO COMBINED BCL-2/MCL-1 BH3 MIMETIC TARGETING IN MULTIPLE MYELOMA CELLS

EHA Library, Martin Grundy, 294836

SOMATIC MUTATIONS IN RAS GENES ARE ASSOCIATED WITH POOR PROGNOSIS IN MULTIPLE MYELOMA

EHA Library, Anna Sergeeva, 294837

LICOCHALCONE A IS A NOVEL SP1 INHIBITOR WITH STRONG ANTI-MYELOMA ACTIVITY

EHA Library, Hua Bai, 294838

EVALUATION OF THE PROGNOSTIC ROLE OF THE BONE MARROW MULTIPARAMETER FLOW CYTOMETRY (MFC) IN NEW DIAGNOSED LIGHT CHAIN AMYLOIDOSIS (AL)

EHA Library, Danilo De Novellis, 294839

A POLYGENIC RISK SCORE FOR MULTIPLE MYELOMA RISK PREDICTION

EHA Library, Angelica Macauda, 294840

REAL TIME GENOMIC AND TRANSCRIPTOMIC PROFILING ALLOWS RAPID STRATIFICATION OF MULTIPLE MYELOMA

EHA Library, Anna Dolnik, 294841

IDENTIFICATION OF CIRCULATING PLASMA CELLS IN MULTIPLE MYELOMA, MGUS AND SMOULDERING MYELOMA BY FLOW CYTOMETRY, USING A SINGLE PLATFORM-QUANTITATIVE METHOD

EHA Library, Giulia Micol Morocutti, 294842

TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA WITH JNJ-4528, A B-CELL MATURATION ANTIGEN (BCMA)-DIRECTED CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELL THERAPY: UPDATE OF PHASE 1B RESULTS FROM CARTITUDE-1

EHA Library, Saad Z. Usmani, 294843

ORVACABTAGENE AUTOLEUCEL (ORVA-CEL), A B-CELL MATURATION ANTIGEN-DIRECTED CAR T CELL THERAPY FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATE OF THE PHASE 1/2 EVOLVE STUDY

EHA Library, Sham Mailankody, 294844

DARATUMUMAB, CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE (DARA-KRD) INDUCTION, AUTOLOGOUS TRANSPLANTATION AND MRD RESPONSE-ADAPTED CONSOLIDATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Luciano J. Costa, 294845

EFFICACY AND TOLERABILITY OF INDUCTION TREATMENT WITH IXAZOMIB, DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN FRAIL NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS – RESULTS OF THE PHASE II HOVON 143 TRIAL

EHA Library, Claudia A.M. Stege, 294846

A PHASE 1B STUDY OF TAK-079, AN INVESTIGATIONAL ANTI-CD38 MONOCLONAL ANTIBODY (MAB) IN PATIENTS WITH RELAPSED/ REFRACTORY MULTIPLE MYELOMA (RRMM): PRELIMINARY RESULTS

EHA Library, Amrita Krishnan, 294848

UNDETECTABLE MEASURABLE RESIDUAL DISEASE (MRD) AS ENDPOINT OF MAINTENANCE THERAPY: RESULTS FROM THE TOURMALINE-MM3 TRIAL OF IXAZOMIB VS PLACEBO MAINTENANCE IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)

EHA Library, Bruno Paiva, 294849

A NEW RISK STRATIFICATION STRATEGY IN NEWLY DIAGNOSED MULTIPLE MYELOMA: AN ANALYSIS ON MATURE DATA FROM EUROPEAN CLINICAL TRIALS WITHIN THE HARMONY BIG DATA PLATFORM

EHA Library, Mattia D'Agostino, 294850

A PHASE 2 STUDY OF BELANTAMAB MAFODOTIN (GSK2857916) IN COMBINATION WITH POMALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FOR PART 1 DOSE FINDING

EHA Library, Suzanne Trudel, 294851